Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialtypharmaceutical company, announced today that John A. Sedor, Presidentof the Company, will present at the Goldman Sachs 27th Annual GlobalHealthcare Conference taking place at the Ritz-Carlton Laguna Niguelin Dana Point, California. The presentation is scheduled for Tuesday,June 13, 2006 at 1:25PM Eastern Time.
This presentation will be broadcast live over the Internet and maybe accessed via the Company's website, www.bentleypharm.com. Inaddition, a replay of the presentation will be available on theCompany's website, shortly after the presentation. The replay will bearchived for 30 days.
Bentley Pharmaceuticals, Inc. is a specialty pharmaceuticalcompany focused on advanced drug delivery technologies andpharmaceutical products. Bentley's proprietary drug technologiesenhance or facilitate the absorption of pharmaceutical compoundsacross various membranes. Bentley also manufactures a growingportfolio of generic and branded pharmaceuticals in Europe for thetreatment of cardiovascular, gastrointestinal, infectious and CNSdiseases through its subsidiary, Laboratorios Belmac, and marketsthese pharmaceutical products through its subsidiaries, LaboratoriosBelmac, Laboratorios Davur, Laboratorios Rimafar and BentleyPharmaceuticals Ireland; and manufactures and markets activepharmaceutical ingredients through its subsidiary, Bentley API.
Copies of Bentley Pharmaceuticals' press releases and otherinformation may be obtained through Bentley's web site atwww.bentleypharm.com.
